Derivatives of pyridoxine for inhibiting HIV integrase

The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	STRANIX BRENT RICHARD, BOUCHARD JEAN-EMMANUEL, MILOT GUY
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	STRANIX BRENT RICHARD BOUCHARD JEAN-EMMANUEL MILOT GUY
description	The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8283366B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8283366B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8283366B23</originalsourceid><addsrcrecordid>eNrjZDBzSS3KLEssySxLLVbIT1MoqCzKTMmvyMxLVUjLL1LIzMvITMosycxLV_DwDANyS1LTixKLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosIWRhbGxmZmTkTERSgBZui1y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Derivatives of pyridoxine for inhibiting HIV integrase</title><source>esp@cenet</source><creator>STRANIX BRENT RICHARD ; BOUCHARD JEAN-EMMANUEL ; MILOT GUY</creator><creatorcontrib>STRANIX BRENT RICHARD ; BOUCHARD JEAN-EMMANUEL ; MILOT GUY</creatorcontrib><description>The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121009&DB=EPODOC&CC=US&NR=8283366B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121009&DB=EPODOC&CC=US&NR=8283366B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STRANIX BRENT RICHARD</creatorcontrib><creatorcontrib>BOUCHARD JEAN-EMMANUEL</creatorcontrib><creatorcontrib>MILOT GUY</creatorcontrib><title>Derivatives of pyridoxine for inhibiting HIV integrase</title><description>The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBzSS3KLEssySxLLVbIT1MoqCzKTMmvyMxLVUjLL1LIzMvITMosycxLV_DwDANyS1LTixKLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosIWRhbGxmZmTkTERSgBZui1y</recordid><startdate>20121009</startdate><enddate>20121009</enddate><creator>STRANIX BRENT RICHARD</creator><creator>BOUCHARD JEAN-EMMANUEL</creator><creator>MILOT GUY</creator><scope>EVB</scope></search><sort><creationdate>20121009</creationdate><title>Derivatives of pyridoxine for inhibiting HIV integrase</title><author>STRANIX BRENT RICHARD ; BOUCHARD JEAN-EMMANUEL ; MILOT GUY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8283366B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>STRANIX BRENT RICHARD</creatorcontrib><creatorcontrib>BOUCHARD JEAN-EMMANUEL</creatorcontrib><creatorcontrib>MILOT GUY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STRANIX BRENT RICHARD</au><au>BOUCHARD JEAN-EMMANUEL</au><au>MILOT GUY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Derivatives of pyridoxine for inhibiting HIV integrase</title><date>2012-10-09</date><risdate>2012</risdate><abstract>The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US8283366B2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	Derivatives of pyridoxine for inhibiting HIV integrase
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T15%3A06%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STRANIX%20BRENT%20RICHARD&rft.date=2012-10-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8283366B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true